Literature DB >> 16824983

Have palliative care teams' attitudes toward venous thromboembolism changed? A survey of thromboprophylaxis practice across British specialist palliative care units in the years 2000 and 2005.

Simon I R Noble1, Ilora G Finlay.   

Abstract

Palliative care patients are highly prothrombotic, yet there are no national guidelines for the prevention of venous thromboembolism (VTE). A survey was undertaken to explore thromboprophylaxis practice within British palliative care inpatient units and whether it changed over 5 years in keeping with emerging evidence. A descriptive semistructured telephone survey was conducted in April, 2000 and March, 2005 to explore current thromboprophylaxis practice. Seventy-four percent of units participated in 2000 and 91% participated in 2005. Units surveyed in 2000 revealed that 2% had thromboprophylaxis guidelines and up to 75% would stop ongoing low molecular weight heparin (LMWH) in a highly prothrombotic, good prognosis inpatient. The survey in 2005 indicated that thromboprophylaxis guidelines were being developed in 19% of units and only 18% of units surveyed would stop LMWH in a patient already receiving thromboprophylaxis (P < 0.001). There appears to be a growing awareness of the problem of VTE in British palliative care inpatients, as evidenced by changes in attitudes and practice. Reasons for this are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16824983     DOI: 10.1016/j.jpainsymman.2005.11.013

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  5 in total

1.  Predictors of anticoagulation in hospice patients with lung cancer.

Authors:  Holly M Holmes; Kevin T Bain; Ali Zalpour; Ruili Luo; Eduardo Bruera; James S Goodwin
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

2.  Thromboprophylaxis in patients receiving inpatient palliative care: a survey of present practice in Austria.

Authors:  Verena Gartner; Katharina A Kierner; Astrid Namjesky; Birgit Kum-Taucher; Bernhard Hammerl-Ferrari; Herbert H Watzke; Cornelia Stabel
Journal:  Support Care Cancer       Date:  2011-11-26       Impact factor: 3.603

3.  Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study.

Authors:  S I R Noble; A Nelson; C Turner; I G Finlay
Journal:  BMJ       Date:  2006-02-03

4.  Prevalence, symptom burden, and natural history of deep vein thrombosis in people with advanced cancer in specialist palliative care units (HIDDen): a prospective longitudinal observational study.

Authors:  Clare White; Simon I R Noble; Max Watson; Flavia Swan; Victoria L Allgar; Eoin Napier; Annmarie Nelson; Jayne McAuley; Jennifer Doherty; Bernadette Lee; Miriam J Johnson
Journal:  Lancet Haematol       Date:  2019-02       Impact factor: 18.959

Review 5.  Thromboprophylaxis in the End-of-Life Cancer Care: The Update.

Authors:  Ewa Zabrocka; Ewa Sierko
Journal:  Cancers (Basel)       Date:  2020-03-05       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.